Overview

Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

This study will compare the pharmacokinetics of omeprazole, rosiglitazone and desipramine when administered with a single oral dose of avanafil in healthy male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

VIVUS, Inc.

Treatments:

Desipramine
Omeprazole
Rosiglitazone